Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Medtronic has expanded a 2018 recall of insulin pump remote controls to include all remote controls used with the MiniMed 508 insulin pump and the MiniMed Paradigm family of insulin pumps.

Medtronic has recalled certain MiniMed 600 Series insulin pumps for delivering incorrect insulin dosing due to a missing or broken retainer ring, which helps lock the insulin cartridge in place in ...

OTTAWA, June 29, 2019 /CNW/ - Health Canada is advising patients and health care providers that certain older Medtronic MiniMed 508 and MiniMed Paradigm insulin pumps distributed between 2010 and ...

Medtronic is urgently recalling remote controllers for insulin pumps belonging to the ‘MiniMed Paradigm’ family of products, due to severe cybersecurity risks. The controllers that should be ...

Medical device maker Medtronic has expanded its recall of remote controllers for its MiniMed 508 and MiniMed Paradigm insulin pumps. The reason? The devices are a potential cybersecurity risk.

The US Food and Drug Administration issued a warning on Thursday about possible risk of hacking for some diabetes patients' insulin pumps. Certain insulin pumps from Medtronic MiniMed have been ...

Medtronic recently introduced the Paradigm 712 insulin pump system, which has the same user-friendly features as the Paradigm 512 insulin pump. The new Paradigm 712 pump holds a larger three ...

If the Paradigm Veo is used with Medtronic’s Enlite CGM sensors, Low Glucose Suspend means that, if you glucose levels become too low, the pump will automatically cease insulin delivery until your ...

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.